Prof. Dr. Meliha Nalçacı

POSTER: CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)00515-3 Quelle: OpenAlex

RETROSPECTIVE EVALUATION OF BONE MARROW FINDINGS IN AUTOIMMUNE HEMOLYTIC ANEMIAS

Hematology Transfusion and Cell Therapy, 2023

DOI 10.1016/j.htct.2023.09.068 Frei zugänglicher VolltextQuelle: OpenAlex

INFECTION RATES ACROSS THE AUTOLOGOUS STEM CELL TRANSPLANTATION WITH REFLECTION OF MULTIPLE MYELOMA INDUCTION STORY IN TURKEY

Hematology Transfusion and Cell Therapy, 2023

DOI 10.1016/j.htct.2023.09.064 Quelle: OpenAlex

Multipl Miyelom ve Lenfomalı Kemoterapi Alan Hastalarda Hepatit B Virüsü Reaktivasyonu ve Aşı Başarısı ile İlişkili Faktörler

LLM Dergi, 2023

DOI 10.5578/llm.20239903 Quelle: OpenAlex

The association of CMV infection with bacterial and fungal infections in hematopoietic stem cell transplant recipients: a retrospective single-center study.

PubMed, 2022

PMID 35403846 4 Zitationen (Europe PMC) Quelle: OpenAlex

Turkey Real-Life Data: Demographic Features, Treatment Results and Effects of Comorbidities in Chronic Myeloid Leukemia

International Journal of Hematologic Oncology, 2022

DOI 10.2217/ijh-2021-0008 PMID 36101779 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Turkish Journal of Hematology, 2022

DOI 10.4274/tjh.galenos.2022.2022.0142 PMID 35657203 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL

HemaSphere, 2022

DOI 10.1097/01.hs9.0000847420.24995.43 Quelle: OpenAlex

PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA

HemaSphere, 2022

DOI 10.1097/01.hs9.0000851128.52895.ec 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

TMED9 is a Predictive Marker of Transition from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Research Square, 2022

DOI 10.21203/rs.3.rs-2370302/v1 Frei zugänglicher VolltextQuelle: OpenAlex

PB1899: DEVELOPMENT AND VALIDATION OF A PREDICTIVE SCORING SYSTEM FOR THE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE RECEIVING FIRST-LINE IMATINIB

HemaSphere, 2022

DOI 10.1097/01.hs9.0000850448.44505.f6 Quelle: OpenAlex

Aberrant Activation-Induced Cytidine Deaminase Gene Expression Links BCR/ABL1-Negative Classical Myeloproliferative Neoplasms

Medical Bulletin of Haseki, 2022

DOI 10.4274/haseki.galenos.2022.8133 Quelle: OpenAlex

Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen

Hematology Reports, 2022

DOI 10.3390/hematolrep14030030 PMID 35893154 Frei zugänglicher VolltextQuelle: OpenAlex

Beta 2 glycoprotein I Valine247Leucine polymorphism in patients with antiphospholipid syndrome

Experimental Biomedical Research, 2022

DOI 10.30714/j-ebr.2022.147 Quelle: OpenAlex

AN UNUSUAL OCULAR LYMPHOMA, PRIMARY INTRAVITREAL LYMPHOMA DIAGNOSED INCIDENTALLY

Hematology Transfusion and Cell Therapy, 2022

DOI 10.1016/j.htct.2022.09.1243 Quelle: OpenAlex

Being an Informal Caregiver in Bone Marrow Transplant Unit: A Qualitative Study

Turkiye Klinikleri Journal of Nursing Sciences, 2022

DOI 10.5336/nurses.2022-89812 Quelle: OpenAlex

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Hematological Oncology, 2021

DOI 10.1002/hon.2897 PMID 34171130 15 Zitationen (Europe PMC) Quelle: OpenAlex

HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia, 2021

DOI 10.1016/s2152-2650(21)01845-0 Quelle: OpenAlex

Poster: HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia, 2021

DOI 10.1016/s2152-2650(21)01484-1 Quelle: OpenAlex

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Kocaeli Üniversitesi - AVESİS, 2021

Quelle: OpenAlex

COVID-19 infection in patients with acute leukemia; Istanbul experience.

Europe PMC (PubMed Central), 2021

PMID 34540352 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms

TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

DOI 10.3906/sag-2103-247 PMID 34482679 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study

Transfusion and Apheresis Science, 2021

DOI 10.1016/j.transci.2021.103243 PMID 34420879 3 Zitationen (Europe PMC) Quelle: OpenAlex

Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series

Leukemia Research, 2021

DOI 10.1016/j.leukres.2021.106725 PMID 34634595 1 Zitation (Europe PMC) Quelle: OpenAlex

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Journal of Chemotherapy, 2021

DOI 10.1080/1120009x.2021.1976912 PMID 34514960 8 Zitationen (Europe PMC) Quelle: OpenAlex

Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis

Annals of Allergy Asthma & Immunology, 2021

DOI 10.1016/j.anai.2021.03.020 PMID 33775901 5 Zitationen (Europe PMC) Quelle: OpenAlex

Activation-induced cytidine deaminase expression in patients with myelodysplastic syndrome and its relationship with prognosis and treatment

TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

DOI 10.3906/sag-2101-81 PMID 34022778 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma

Frontiers in Oncology, 2021

DOI 10.3389/fonc.2021.601709 PMID 33816231 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

A case mimicking chronic myeloid leukemia with t(8;22)(p11;q11)/BCR-FGFR1 and sequential transformation to B-acute lymphoblastic leukemia and acute myeloid leukemia

Journal of Hematopathology, 2021

DOI 10.1007/s12308-020-00429-1 Quelle: OpenAlex

Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia

Indian Journal of Hematology and Blood Transfusion, 2021

DOI 10.1007/s12288-021-01445-6 PMID 35496969 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey

İstanbul Kanuni Sultan Süleyman Tıp Dergisi, 2021

DOI 10.4274/iksstd.2021.35761 Quelle: OpenAlex

R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Blood, 2021

DOI 10.1182/blood-2021-145810 Quelle: OpenAlex

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

Hematology Transfusion and Cell Therapy, 2021

DOI 10.1016/j.htct.2021.10.1063 Quelle: OpenAlex

Assessment of Left Ventricular Function using a Two-Dimensional Speckle Tracking Echocardiography in Asymptomatic Survivors of Hodgkin’s Lymphoma in Long-Term Follow-Up

Istanbul Medical Journal, 2021

DOI 10.4274/imj.galenos.2021.07448 Quelle: OpenAlex

BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE

AYBU AVESIS, 2020

Quelle: OpenAlex

A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma

Case Reports in Hematology, 2020

DOI 10.1155/2020/5738319 PMID 32733716 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Budd-Chiari Syndrome: An Unusual Complication of AL amyloidosis

Turkish Journal of Hematology, 2020

DOI 10.4274/tjh.galenos.2020.2019.0186 PMID 32126743 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center ‘Real-Life’ Experience

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2020

DOI 10.5222/bmj.2020.28290 Quelle: OpenAlex

COVID-19 ve Miyelodisplastik Sendrom

Türkiye Klinikleri COVID - 19, 2020

Quelle: OpenAlex

Pure Red Cell Aplasia in IgG4-Related Disease: Successful Treatment With Cyclosporine

JCR Journal of Clinical Rheumatology, 2020

DOI 10.1097/rhu.0000000000001666 PMID 33323754 1 Zitation (Europe PMC) Quelle: OpenAlex

The frequency of calreticulin and mpl gene mutations in bcr-abl and jak2 unmutated chronic myeloproliferative neoplasms and its effect on the outcome

Hematology Transfusion and Cell Therapy, 2020

DOI 10.1016/j.htct.2020.09.078 Quelle: OpenAlex

Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience

Hematology Transfusion and Cell Therapy, 2020

DOI 10.1016/j.htct.2020.09.087 Quelle: OpenAlex

Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data

Blood, 2020

DOI 10.1182/blood-2020-138899 Quelle: OpenAlex

MPN-376: The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/s2152-2650(20)31007-7 Quelle: OpenAlex

MPN-364: The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/s2152-2650(20)31006-5 Quelle: OpenAlex

A practical 16-day desensitization protocol in lenalidomide-induced non-immediate hypersensitivity reactions

Annals of Allergy Asthma & Immunology, 2019

DOI 10.1016/j.anai.2019.07.031 PMID 31400463 4 Zitationen (Europe PMC) Quelle: OpenAlex

The Clinical Significance of JAK2V617F Mutation for Philadelphia–Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis

Clinical Lymphoma Myeloma & Leukemia, 2019

DOI 10.1016/j.clml.2019.07.377 2 Zitationen (OpenAlex) Quelle: OpenAlex

Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Study

Clinical Lymphoma Myeloma & Leukemia, 2019

DOI 10.1016/j.clml.2019.07.198 Quelle: OpenAlex

The efficacy of reuse therapeutic plasma exchange in relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a single-center experience of 130 cases

Leukemia Research, 2019

DOI 10.1016/s0145-2126(19)30330-3 Quelle: OpenAlex

PB1933 CLINICAL FEATURES AND TREATMENT OUTCOMES OF CHRONIC PHASE‐CHRONIC MYELOID LEUKEMIA PATIENTS IN TURKEY: REAL‐WORLD DATA

HemaSphere, 2019

DOI 10.1097/01.hs9.0000566228.27858.e5 Frei zugänglicher VolltextQuelle: OpenAlex